Hovione expansion provides integrated full-service solution21 Mar 2018
Additional capacity expansion across several of the company's sites also strengthens the company's global market leadership in spray drying.
Hovione has announced recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey, with the aim to increase capacity in existing technologies, such as spray drying and to grow in new areas of business to support client demand.
The capacity expansion program, which started in 2016, will continue during the next 5 years. The first 2 years saw Hovione relocate its development services to a new 7000 m2 centre in Lisbon, 15 minutes away from the Loures manufacturing site. The new Lisbon site is fully equipped to handle potent and highly potent compounds, and hosts 200 scientists specialising in chemistry, particle engineering, formulation and analytical development.
During this period, the Loures site expanded its drug substance reaction vessel capacity with a small-scale production area and a new pilot plant, totalling an extra 30 m3 of capacity. In addition, one pilot and two large-scale spray dryers were installed at the site and started the operation of a new drug product centre equipped with oral dosage form and inhalation manufacturing capabilities.
During the same time, Hovione doubled the size of its development and manufacturing operations in the New Jersey site, providing it with a full range of capabilities, from chemical and analytical development, through spray drying to formulation. The site now hosts 14 m3 of reaction vessel capacity with four independent trains, a pilot and a large scale spray dryer, and a continuous tableting unit.
At the Cork site, Hovione is reinstating and renewing a production building with 157 m3 of chemical synthesis capacity devoted to contract manufacturing. About half of this capacity will be ready for operation by May 2018.
During the next 3 years, Hovione will add to the Loures site a new chemical synthesis and spray dryer building for contract manufacturing, with a total area of 4,200 m2 for 165 m3 of reaction vessel capacity and two large spray drying units, new formulation facilities, which will enable the production of bigger batch sizes, and a new building that will host an additional 1200 m2 of analytical laboratories.
This investment is being paired with recruiting and training new staff, as illustrated by the company's 39% headcount growth in the last 2 years.
“This addition in capacity expansion will secure our growth and ensure that we continue to provide a truly integrated full-service solution to our customers, as well as showing Hovione’s strategy and commitment to further strengthen its global market leadership in spray drying,” said Frédéric Kahn, Vice-President Marketing & Sales.
“This capacity expansion plan is far more than a matter of production capacity solely. It aims to reorganize sites with new buildings, renew existing facilities and give operations the most advanced equipment in the market, to provide our customers and team members with the technology and the capacity they need to grow in a sustainable way. It is a significant effort and commitment from Hovione to stay ahead of and prepare for future demand.” said Nuno Almeida, Vice-President of Engineering.
HALIX starts operational production with new cGMP facility in Q4-2019
15 Aug 2019
The five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors and a separate protein manufacturing area with a capacity up to 1,000-L single-use bioreactors.Read more
Delivering complete aseptic vial handling solutions
14 Aug 2019
Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.Read more
Hikma expands nasal spray capabilities
12 Aug 2019
Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.Read more
How real-world data can revolutionise drug development
9 Aug 2019
Utilising the current data environment and its data pools for the benefit of advancing research.Read more
Sartorius launches new services for mammalian cell bank manufacturing
8 Aug 2019
Integrated package of new and established services saves time and minimizes risks.Read more
Using mobile phones to fight Alzheimer’s disease
8 Aug 2019
Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy.Read more
Cambrex to be acquired by the Permira funds
7 Aug 2019
The CDMO's shareholders will receive $60.00 per share in cash.Read more
Automation-compatible prepared culture media plate technology
6 Aug 2019
Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.Read more
Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings
6 Aug 2019
The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.Read more
Growing domestic manufacturing creates new opportunities for international pharma in the Middle East
5 Aug 2019
Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation